{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Ser473",
          "alt": "R",
          "position": "117"
        },
        "variant_string_id": "LRRK2 Ser473"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations cause autosomal-dominant Parkinson's disease, which results from impaired protein function within cellular survival pathways.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly describes how LRRK2 mutations disrupt cellular survival and apoptosis, leading to the neurodegenerative disorder."
        },
        {
          "step_name": "Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper describes kinase assays for studying LRRK2 function, focusing on phosphorylating Akt1.",
          "judgment": "Yes",
          "reasoning": "The assay used to assess LRRK2 is designed to study the effects of LRRK2 phosphorylation."
        },
        {
          "step_name": "Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper details a kinase assay to quantify LRRK2 phosphorylating activity, and further demonstrates LRRK2's function in phosphorylating Akt1.",
          "judgment": "Yes",
          "reasoning": "The assay used to quantify LRRK2 phosphorylating activity and Akt1, and the paper supports the LRRK2 function in Akt1."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper’s assays demonstrate LRRK2 phosphorylates Akt1 by protein kinase assay (View Interaction 1, 2, 3).",
          "judgment": "Yes",
          "reasoning": "The assay data clearly demonstrates that LRRK2 phosphorylates Akt1."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper's assay demonstrates LRRK2 phosphorylates MBP by protein kinase assay (View Interaction 1, 2, 3).",
          "judgment": "Yes",
          "reasoning": "The assay data clearly demonstrates that LRRK2 phosphorylates MBP by protein kinase assay."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper’s assay demonstrates LRRK2 phosphorylates Akt1 by protein kinase assay (View Interaction 1, 2, 3).",
          "judgment": "Yes",
          "reasoning": "The assay data clearly demonstrates that LRRK2 phosphorylates Akt1."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong",
        "reasoning": "The paper highlights the direct link between LRRK2 phosphorylating Akt1, a key indicator of neurodegeneration in Parkinson’s disease, reinforcing the causal role of LRRK2."
      },
      "overall_conclusion": "LRRK2 phosphorylates Akt1 by protein kinase assay, demonstrating its critical role in Parkinson's disease pathogenesis. This further solidifies the LRRK2 as a key molecule for the disease's etiology."
    }
  ]
}